New therapeutic vaccine approach holds promise for HIV remission
Combining an experimental vaccine with an innate immune stimulant could assist result in viral remission in individuals residing with HIV . (inventory picture) Credit score: © jarun011 / Fotolia A examine led by researchers at Beth Israel Deaconess Medical Heart (BIDMC), in collaboration with scientists at Walter Reed Military Institute of Analysis (WRAIR), Janssen Vaccines & Prevention B.V., one of many Janssen Pharmaceutical Firms of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant could assist result in viral remission in individuals residing with HIV. In animal trials, the mix decreased ranges of viral DNA in peripheral blood and lymph nodes, and improved viral suppression and delayed viral rebound following discontinuation of anti-retroviral remedy (ART). The analysis staff's findings appeared on-line at this time within the journal ...